Approval for a revised laparoscopic surgical technique for implantation of the lt-cage.  The device remains marketed under the trade name lt-cage tapered fusion device and is indicated for spinal fusion procedures in skeletally mature patients with degenerative disc disease (ddd) at one level form l2-s1.  Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies.  These ddd patients may also have up to grade i spondylolisthesis or retrolisthesis at the involved level.  Lt-cage implants are to be used with autogenous bone graft and implanted via a laparoscopic or an open anterior approach.  Patients receiving the lt-cage lumbar tapered fusion device should have had at least six months of nonoperative treatment prior treatment with the lt-cage.